Haemonetics Corp (HAE)

NYSE

$78.22

Haemonetics Corporation, a healthcare company, offers medical products and solutions. The company is headquartered in Boston, Massachusetts.

Sector:

Industry:

68 analysts

Buy

Target: $86.60 (+10.71%)

Market Cap

$3.47B

FCF 5Y CAGR

+29.41%

Forward P/E

14.93

P/E Ratio

37.53

Adjust inflation

Log

Valuation

Market Cap$3.47B

P/E37.53

Forward P/E14.93

PEG1.23

P/S2.54

P/B4.39

Profitability

Total Revenue (TTM)$1.33B

Gross Profit (TTM)$793M

EBITDA$268M

Profit Margin-5.8%

Operating Margin-6.6%

EPS$2.04

Financial Health

Debt-to-Equity153.8%

Free Cash Flow Yield7.50%

Growth & Risk

EPS 5Y CAGR+5.46%

Revenue 5Y CAGR+8.91%

FCF 5Y CAGR+29.41%

Beta (5Y)0.55

Sharpe Ratio0.31